PFM Health Sciences’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-742,138
| Closed | -$14.2M | – | 81 |
|
|
2022
Q3 | $14.2M | Sell |
742,138
-435,112
| -37% | -$8.3M | 0.51% | 54 |
|
|
2022
Q2 | $21.4M | Sell |
1,177,250
-705,107
| -37% | -$12.8M | 0.82% | 45 |
|
|
2022
Q1 | $47.4M | Sell |
1,882,357
-143,324
| -7% | -$3.61M | 1.77% | 20 |
|
|
2021
Q4 | $55.9M | Sell |
2,025,681
-847,237
| -29% | -$23.4M | 1.9% | 18 |
|
|
2021
Q3 | $92.8M | Sell |
2,872,918
-216,234
| -7% | -$6.98M | 2.73% | 9 |
|
|
2021
Q2 | $94.5M | Buy |
3,089,152
+370,529
| +14% | +$11.3M | 2.96% | 8 |
|
|
2021
Q1 | $82.8M | Buy |
+2,718,623
| New | +$82.8M | 2.53% | 8 |
|
|
2014
Q2 | – | Sell |
-40,491
| Closed | -$1.38M | – | 73 |
|
|
2014
Q1 | $1.38M | Sell |
40,491
-365,612
| -90% | -$12.5M | 0.03% | 70 |
|
|
2013
Q4 | $8.52M | Buy |
406,103
+258,727
| +176% | +$5.43M | 0.17% | 53 |
|
|
2013
Q3 | $3.46M | Buy |
+147,376
| New | +$3.46M | 0.08% | 68 |
|